These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6398629)

  • 1. Methotrexate. I. Pharmacology and pharmacokinetics.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
    Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
    Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light activates reduction of methotrexate by NADPH in the ternary complex with Escherichia coli dihydrofolate reductase.
    Chen YQ; Gulotta M; Cheung HT; Callender R
    Photochem Photobiol; 1999 Jan; 69(1):77-85. PubMed ID: 10063803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine.
    Sirotnak FM; Moccio DM; Yang CH
    Cancer Res; 1984 Nov; 44(11):5204-11. PubMed ID: 6488181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability.
    Dams T; Auerbach G; Bader G; Jacob U; Ploom T; Huber R; Jaenicke R
    J Mol Biol; 2000 Mar; 297(3):659-72. PubMed ID: 10731419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
    Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
    Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbon-13 nuclear magnetic resonance study of protonation of methotrexate and aminopterin bound to dihydrofolate reductase.
    Cocco L; Groff JP; Temple C; Montgomery JA; London RE; Matwiyoff NA; Blakley RL
    Biochemistry; 1981 Jul; 20(14):3972-8. PubMed ID: 7284303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli.
    Williams MN; Poe M; Greenfield NJ; Hirshfield JM; Hoogsteen K
    J Biol Chem; 1973 Sep; 248(18):6375-9. PubMed ID: 4147159
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase.
    Ercikan E; Waltham M; Dicker A; Schweitzer B; Bertino JR
    Adv Exp Med Biol; 1993; 338():515-9. PubMed ID: 8304170
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence and properties of dihydrofolate reductases within the genus Trypanosoma.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Br J Pharmacol; 1968 Sep; 34(1):191P-192P. PubMed ID: 4300138
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of oral methotrexate in children.
    Balis FM; Savitch JL; Bleyer WA
    Cancer Res; 1983 May; 43(5):2342-5. PubMed ID: 6572562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of trimetrexate (NSC 352122) in monkeys.
    Balis FM; Lester CM; Poplack DG
    Cancer Res; 1986 Jan; 46(1):169-74. PubMed ID: 2933145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a high-molecular-weight nonfunctional protein in L1210 leukemia cells with common antigenic determinants to dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Cancer Res; 1983 Feb; 43(2):529-35. PubMed ID: 6184148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate.
    Schlegel HB; Poe M; Hoogsteen K
    Mol Pharmacol; 1981 Jul; 20(1):154-8. PubMed ID: 7027022
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mathematical description and study of the folic acid cycle reactions].
    Vorontsov IN; Greshilov MM; Belousova AK; Gerasimova GK
    Biokhimiia; 1980 Jan; 45(1):83-97. PubMed ID: 6783126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consideration of the pH-dependent inhibition of dihydrofolate reductase by methotrexate.
    Cannon WR; Garrison BJ; Benkovic SJ
    J Mol Biol; 1997 Aug; 271(4):656-68. PubMed ID: 9281432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of methotrexate, aminopterin, and methasquin and inhibition of dihydrofolate reductase and of DNA synthesis in mouse small intestine.
    Philips FS; Sirotnak FM; Sodergren JE; Hutchison DJ
    Cancer Res; 1973 Jan; 33(1):153-8. PubMed ID: 4682318
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of methotrexate, folates, and pyridine nucleotides with dihydrofolate reductase: calorimetric and spectroscopic binding studies.
    Subramanian S; Kaufman BT
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3201-5. PubMed ID: 28523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.